Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Krebs Biochemicals & Industries Limited
KREBSBIO | NSE
65.01
INR-0.53
-0.81%
KREBSBIO | NSE
Loading StockChartView...
About Krebs Biochemicals & Industries Limited
Sector
Healthcare
Industry
Drug Manufacturers-Specialty & Generic
Earnings date
31/03/2024
As of date
05/06/2026
Close
65.01
Open
65.60
High
66.98
Low
63.10
Krebs Biochemicals & Industries Limited manufactures and sells active pharmaceutical ingredients in India. The company develops biotech processes for application in medicine agriculture and industry fields. Its products include androstenedione lovastatin and simvastatin which are used for anti-cholesterol and steroid intermediate applications. The company is also developing various products including amlodipine cetirizine orlistat serratiopepetidase telmisartan and phenylephrine for anti-hypertension anti-histamine anti-obesity anti-inflammatory and cold and cough applications. In addition it offers contract manufacturing services for large pharmaceutical and multinational companies. The company was incorporated in 1991 and is headquartered in Hyderabad India.
View LessKREBSBIO | NSE
Risk
49.0
Sharpe
-0.33
Luna's Score
55/100
Recommendation
Hold
Luna says (KREBSBIO | NSE)
What's Working
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Strong Revenue Growth (> 10%)
What's not Working
Microcap (<300M USD)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
Loading RiskMeterView...
10 days
55.2%1 month
49.0%3 months
73.8%6 months
61.0%Returns
Loading ReturnMeterView...
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
-
Debt to equity
-1.62
Debt to assets
1.09
Ent. to EBITDA
-16.12
Ent. to rev.
8.28
PEG
-
Other Fundamentals
EBITDA
-77.92M
MarketCap
1.40B
MarketCap(USD)
14.71M
Div. yield
-
Op. margin
-29.89
Erngs. growth
-
Rev. growth
21.80
Ret. on equity
-
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Loading MovingAverageView...
Range10D
16.25
Range1M
16.93
Range3M
32.92
Volumes: Market Activity
Volume Averages
Loading VolumeAverageView...
Rel. volume
0.57
Price X volume
266.22K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -16.12 | 24.85 | Cheaper |
| Ent. to Revenue | 8.28 | 11.40 | Cheaper |
| PE Ratio | - | 51.36 | - |
| Price to Book | - | 6.83 | - |
| Dividend Yield | - | 0.52 | - |
| Std. Deviation (3M) | 73.83 | 42.17 | Riskier |
| Debt to Equity | -1.62 | 0.35 | Cheaper |
| Debt to Assets | 1.09 | 0.17 | Expensive |
| Market Cap | 1.40B | 290.82B | Emerging |
